Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

Rhea-AI Summary

Fennec Pharmaceuticals (NASDAQ: FENC; TSX: FRX) has announced its participation in the 15th Annual Craig-Hallum Alpha Select Conference. The event will take place on November 19, 2024, at the Sheraton New York Times Square Hotel in New York City. The company's management team will be available for one-on-one meetings throughout the conference. Fennec Pharmaceuticals, a commercial stage specialty pharmaceutical company, will use this platform to engage with investors and present their business updates.

News Market Reaction

+5.91%

1 alert

+5.91% News Effect

On the day this news was published, FENC gained 5.91%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will be participating in the 15th Annual Craig-Hallum Alpha Select Conference. The Company's management will be available for one-on-one meetings throughout the event.

Conference Details:

Event: 15th Annual Craig-Hallum Alpha Select Conference
Date: November 19, 2024
Location: Sheraton New York Times Square Hotel, New York City

About Fennec Pharmaceuticals
Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. Further, PEDMARK received FDA approval in September 2022 and European Commission approval in June 2023 and U.K. approval in October 2023 under the brand name PEDMARQSI. PEDMARK has received Orphan Drug Exclusivity in the U.S. and PEDMARQSI has received Pediatric Use Marketing Authorization in Europe, which includes eight years plus two years of data and market protection. For more information, please visit www.fennecpharma.com.

For further information, please contact:

Investors:
Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
+1 919-246-5299

Corporate & Media:
Lindsay Rocco 
Elixir Health Public Relations
+1 862-596-1304
lrocco@elixirhealthpr.com

FAQ

When is Fennec Pharmaceuticals (FENC) participating in the Craig-Hallum Alpha Select Conference?

Fennec Pharmaceuticals will participate in the 15th Annual Craig-Hallum Alpha Select Conference on November 19, 2024.

Where will the Craig-Hallum Conference featuring Fennec Pharmaceuticals (FENC) be held?

The conference will be held at the Sheraton New York Times Square Hotel in New York City.

What type of investor meetings will Fennec Pharmaceuticals (FENC) offer at the Craig-Hallum Conference?

Fennec Pharmaceuticals' management will be available for one-on-one meetings throughout the event.

Which stock exchanges is Fennec Pharmaceuticals listed on?

Fennec Pharmaceuticals is listed on NASDAQ under the symbol FENC and on the Toronto Stock Exchange under the symbol FRX.